National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National HealthCare Corporation (NHC) is the issuer in an amended ownership report by First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation. Each reported 713,812 common shares beneficially owned, or 4.56% of the class, while disclaiming beneficial ownership.
The ownership breakdown lists shared voting power over 703,067 shares for First Trust Advisors L.P. and The Charger Corporation. The report separately states that none of the three reporting parties can vote shares held by unit investment trusts sponsored by First Trust Portfolios L.P.
NATIONAL HEALTHCARE CORP (NHC) Sr. VP Patient Srvcs Vicki L. Dodson sold 4,834 shares of common stock at $225.00 per share on September 22, 2026, leaving reported direct holdings of 10,726 shares. The filing lists three direct options to purchase common stock: 4,000 shares at a $94.10 exercise price, expiring March 5, 2029; 9,000 shares at $90.62, expiring February 24, 2030; and 14,000 shares at $157.13, expiring February 23, 2031. No Rule 10b5-1 plan is reported.
NATIONAL HEALTHCARE CORP (NHC) reported that Senior VP & General Counsel Josh A. McCreary sold a total of 2,719 shares of common stock on September 10, 2026, in open-market transactions at weighted average prices around $223–$226 per share. No Rule 10b5-1 trading plan is reported. McCreary continues to hold multiple stock option awards covering shares of NHC common stock.
NATIONAL HEALTHCARE CORP (NHC) reported that Senior Vice President and Chief Financial Officer Brian F. Kidd sold 6,813 shares of common stock on September 11, 2026 in an open-market or private transaction at $225.70 per share, leaving him with 23,183 common shares held directly. He also reports directly held options to purchase common stock with exercise prices of $53.94 (4,147 underlying shares, expiring March 8, 2028), $94.10 (4,000 shares, expiring March 5, 2029), $90.62 (9,000 shares, expiring February 24, 2030), and $157.13 (14,000 shares, expiring February 23, 2031). No Rule 10b5-1 trading plan is reported for this transaction.
NATIONAL HEALTHCARE CORP (NHC) is named as the issuer in a Form 144 notice filed for the planned sale of common stock beneficially owned by officer Josh A. McCreary. The filing reports a proposed sale of 2,719 shares of NHC common stock, with an aggregate market value of $600,817.00, through Janney Montgomery Scott on the NYSE, in reliance on Rule 144.
The shares derive from prior equity compensation, including restricted stock vesting on January 1, 2022 and multiple stock option exercises in 2023 and 2024 via net exercise transactions. The filing also lists 15,661,395 shares of NHC common stock as outstanding as of September 10, 2026 as a reference figure.
NATIONAL HEALTHCARE CORP (NHC) reports that Senior VP & CIO Ben Anderson Flatt Sr. sold a total of 7 blocks of 1,000 shares of common stock each in open-market or private transactions between August 12, 2026 and August 28, 2026, at prices from $221.21 to $237.18 per share. No Rule 10b5-1 trading plan is reported for these sales. He continues to hold options to purchase National Healthcare Corp common stock, including options exercisable for 4,000 shares at $94.10 expiring March 5, 2029, 9,000 shares at $90.62 expiring February 24, 2030, and 14,000 shares at $157.13 expiring February 23, 2031.
NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported a sale of company common stock. On 2026-08-25 he sold 1,779 shares of common stock in an open-market or private transaction at $225.42 per share, and now directly holds 1,030 shares of NHC common stock.
NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported an option exercise and related share withholding. On August 20, 2026, he exercised 6,479 stock options granted under the 2020 Omnibus Equity Incentive Plan at an exercise price of $171.42 per share, receiving 6,479 common shares. In a separate transaction the same day, 4,691 common shares were withheld by the company at $236.75 per share to pay the exercise price. The options were granted on May 7, 2026 and are exempt from Section 16(b) under Rule 16b-3(d).
NATIONAL HEALTHCARE CORP (NHC) reported that CEO and director Stephen Fowler Flatt sold 1,500 shares of Common Stock on 2026-08-19 at $237.08 per share in an open-market or private sale, leaving him with 65,487 directly held shares. He also continues to hold several option awards on NHC Common Stock with varying exercise prices and expirations.
NATIONAL HEALTHCARE CORP director David R. Gifford reported an option exercise on August 13, 2026. He exercised 1,021 options from a 2026 grant with an exercise price of $171.42 per share, receiving 1,021 shares of common stock. After the transactions, he directly holds 1,021 common shares and 6,479 options from this grant, which was issued under the 2020 Omnibus Equity Incentive Plan and is stated as exempt from Section 16(b) under Rule 16b-3(d).